Home > Systematic review on hepatitis B and C prevalence in the EU/EEA.

European Centre for Disease Prevention and Control. [ECDC] (2016) Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC. 133 p.

[img]
Preview
PDF (Systematic review on hepatitis B and C prevalence in the EU/EEA)
3MB

Because chronic hepatitis B and C infections are typically asymptomatic, notification data reflect national screening and testing practices and do not give accurate insights into the prevalence of infections. In order to inform prevention efforts, supplementary information such as prevalence data are needed. ECDC conducted a systematic review of the literature published between 2005–2015, with the aim to estimate the prevalence of hepatitis B and C in the general population and specific population subgroups in the EU/EEA Member States. This review is an update of an earlier review covering the period 2000–2009.


Item Type:Evidence resource
Publication Type:Review
Drug Type:Alcohol or other drugs in general
Intervention Type:AOD disorder harm reduction
Source:ECDC
Date:November 2016
Pages:133 p.
Publisher:ECDC
Corporate Creators:European Centre for Disease Prevention and Control
Place of Publication:Stockholm
EndNote:View
Related URLs:
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis B
G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control
VA Geographic area > Europe
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page